MSS/ MMRp

我们是谁

  • 4 月 5, 2022
    肝动脉灌注奥沙利铂联合全身 FOLFIRI 化疗和贝伐珠单抗治疗纯肝结直肠癌肝转移瘤 (CRLM)患者：最初无法手术的纯肝结直肠癌肝转移瘤患者转为完全切除术。
  • 4 月 5, 2022
    Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.
  • 4 月 5, 2022
    A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors
  • 4 月 5, 2022
    Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers
  • 4 月 5, 2022
    Adoptive Cell Therapy Across Cancer Diagnoses
  • 4 月 5, 2022
    治疗寡转移性实体瘤患者的全身疗法与局部巩固疗法
  • 4 月 5, 2022
    Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
  • 4 月 5, 2022
    Pembrolizumab和Olaparib治疗同源重组缺陷（HRD）晚期结直肠癌（CRC）。
  • 4 月 5, 2022
    Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer
  • 4 月 5, 2022
    庚妥尼单抗（GB226）联合福喹替尼治疗转移性结直肠癌